An update from Qol Holdings Co ( (JP:3034) ) is now available.
Qol Holdings Co., Ltd. reported significant financial growth for the fiscal year ended March 31, 2025, with a 46.6% increase in net sales and a 61.8% rise in operating profit compared to the previous year. The company also announced the inclusion of DAIICHI SANKYO ESPHA CO., LTD. in its consolidation scope, indicating strategic expansion efforts. The financial results suggest a strong market position and potential positive implications for stakeholders, as evidenced by the forecasted increase in dividends and earnings per share for the upcoming fiscal year.
More about Qol Holdings Co
Qol Holdings Co., Ltd. is a company listed on the Tokyo Stock Exchange, operating in the pharmaceutical and healthcare industry. The company focuses on providing pharmaceutical products and services, with a market emphasis on enhancing healthcare solutions.
Average Trading Volume: 280,470
Current Market Cap: Yen80.86B
Learn more about 3034 stock on TipRanks’ Stock Analysis page.